4BIO Capital Revenue and Competitors
Estimated Revenue & Valuation
- 4BIO Capital's estimated annual revenue is currently $3.5M per year.
- 4BIO Capital's estimated revenue per employee is $205,882
Employee Data
- 4BIO Capital has 17 Employees.
- 4BIO Capital grew their employee count by 13% last year.
4BIO Capital's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | DIRECTOR, INVESTMENT | Reveal Email/Phone |
3 | Associate | Reveal Email/Phone |
4 | Paralegal and Compliance Assistant | Reveal Email/Phone |
5 | Equity Analyst - Biotech | Reveal Email/Phone |
6 | Managing Partner | Reveal Email/Phone |
7 | Partner, General Counsel | Reveal Email/Phone |
8 | Venture Partner | Reveal Email/Phone |
9 | MANAGING PARTNER | Reveal Email/Phone |
10 | Venture Partner | Reveal Email/Phone |
4BIO Capital Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.5M | 28 | N/A | N/A | N/A |
#2 | $15M | 159 | 15% | $2.15B | N/A |
#3 | $3.5M | 27 | 0% | N/A | N/A |
#4 | $3.5M | 8 | -11% | N/A | N/A |
#5 | $15M | 194 | 7% | N/A | N/A |
#6 | $1.7M | 101 | 7% | N/A | N/A |
#7 | $15M | 57 | -41% | N/A | N/A |
#8 | $15M | 55 | -8% | N/A | N/A |
#9 | N/A | 56 | 40% | N/A | N/A |
#10 | $15M | 15 | -65% | N/A | N/A |
What Is 4BIO Capital?
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO's objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, please visit www.4biocapital.com
keywords:N/A
N/A
Total Funding
17
Number of Employees
$3.5M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 17 | -11% | N/A |
#2 | $1.3M | 17 | N/A | $8M |
#3 | $1.5M | 17 | 0% | N/A |
#4 | $1.5M | 17 | -41% | N/A |
#5 | $2.2M | 17 | -6% | N/A |